{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:48:59Z","timestamp":1782200939971,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016175","name":"Chulabhorn Royal Academy","doi-asserted-by":"publisher","award":["112\/2564"],"award-info":[{"award-number":["112\/2564"]}],"id":[{"id":"10.13039\/100016175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jiph.2026.103150","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:18:43Z","timestamp":1768407523000},"page":"103150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-exposure prophylaxis with favipiravir among household close contacts to confirmed COVID-19 cases: A cluster-randomized trial (PEPfavi)"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7256-9982","authenticated-orcid":false,"given":"Taweegrit","family":"Siripongboonsitti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-9866","authenticated-orcid":false,"given":"Teerapat","family":"Ungtrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriangkrai","family":"Tawinprai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krongkwan","family":"Niemsorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6777-2492","authenticated-orcid":false,"given":"Kunsuda","family":"Punjachaipornpol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worrawat","family":"Sangwipasnapaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natcha","family":"Wattanapokasilp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Muadchimkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saowanee","family":"Wongpatcharawarakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonwan","family":"Soonklang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithi","family":"Mahanonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jiph.2026.103150_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ije\/dyab057","article-title":"HOSTED-England's household transmission evaluation dataset: preliminary findings from a novel passive surveillance system of COVID-19","volume":"50","author":"Hall","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.jiph.2026.103150_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22240","article-title":"Factors associated with household transmission of SARS-CoV-2: an updated systematic review and meta-analysis","volume":"4","author":"Madewell","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.jiph.2026.103150_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9317","article-title":"Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis","volume":"5","author":"Madewell","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.jiph.2026.103150_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.31756","article-title":"Household transmission of SARS-CoV-2: a systematic review and meta-analysis","volume":"3","author":"Madewell","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.jiph.2026.103150_bib5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3201\/eid2810.220494","article-title":"SARS-CoV-2 secondary attack rates in vaccinated and unvaccinated household contacts during replacement of delta with omicron variant, Spain","volume":"28","author":"L\u00f3pez-Mu\u00f1oz","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"13","key":"10.1016\/j.jiph.2026.103150_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19138068","article-title":"Increased secondary attack rates among the household contacts of patients with the omicron variant of the coronavirus disease 2019 in Japan","volume":"19","author":"Ogata","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.jiph.2026.103150_bib7","article-title":"Assessing favipiravir impact on SARS-CoV-2 transmission within households: insights from a multi-center study (FaviPrev)","volume":"10","author":"Siripongboonsitti","year":"2024","journal-title":"J Virus Erad"},{"key":"10.1016\/j.jiph.2026.103150_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijid.2022.09.032","article-title":"Effect of inactivated SARS-CoV-2 vaccines and ChAdOx1 nCoV-19 vaccination to prevent COVID-19 in Thai households (VacPrevent trial)","volume":"124","author":"Muadchimkaew","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2026.103150_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijregi.2021.09.001","article-title":"Transmissibility of SARS-CoV-2 variants as a secondary attack in Thai households: a retrospective study","volume":"1","author":"Watanapokasin","year":"2021","journal-title":"IJID Reg"},{"issue":"8","key":"10.1016\/j.jiph.2026.103150_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJMc2107717","article-title":"Effect of vaccination on household transmission of SARS-CoV-2 in England","volume":"385","author":"Harris","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jiph.2026.103150_bib11","article-title":"Vaccinated COVID-19 index cases are less likely to transmit SARS-CoV-2 to their household contacts: a cohort study","volume":"12","author":"Godoy","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.jiph.2026.103150_bib12","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e9","article-title":"Vaccine effect on household transmission of omicron and delta SARS-CoV-2 variants","volume":"38","author":"Kim","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jiph.2026.103150_bib13","article-title":"Assessing the effects of SARS-CoV-2 vaccination on the risk of household transmission during delta variant circulation: a population-based data linkage cohort study","volume":"42","author":"Vogt","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"6","key":"10.1016\/j.jiph.2026.103150_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial","volume":"285","author":"Welliver","year":"2001","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.jiph.2026.103150_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1915341","article-title":"Baloxavir marboxil for prophylaxis against influenza in household contacts","volume":"383","author":"Ikematsu","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jiph.2026.103150_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa2309002","article-title":"Oral nirmatrelvir-ritonavir as postexposure prophylaxis for Covid-19","volume":"391","author":"Hammond","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jiph.2026.103150_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jinf.2023.08.016","article-title":"Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial","volume":"87","author":"Alpizar","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2026.103150_bib18","article-title":"Role of favipiravir in the treatment of COVID-19","author":"Joshi","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103150_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42195-x","article-title":"Favipiravir treatment in non-severe COVID-19: promising results from multicenter propensity score-matched study (FAVICOV)","volume":"13","author":"Siripongboonsitti","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2026.103150_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2020.11.142","article-title":"Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial","volume":"103","author":"Udwadia","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103150_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90551-6","article-title":"The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials","volume":"11","author":"Hassanipour","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jiph.2026.103150_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12879-021-06164-x","article-title":"Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis","volume":"21","author":"Manabe","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2026.103150_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107021","article-title":"Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: a randomized controlled trial in Thailand","volume":"143","author":"Salvadori","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.jiph.2026.103150_bib24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/psp4.12685","article-title":"Population pharmacokinetics of favipiravir in patients with COVID-19","volume":"10","author":"Irie","year":"2021","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"10.1016\/j.jiph.2026.103150_bib25","unstructured":"World Health Organization. Household transmission investigation protocol for 2019-novel coronavirus (COVID-19) infection. Epidemiological protocol. 2020;28."},{"issue":"7","key":"10.1016\/j.jiph.2026.103150_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012328","article-title":"Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis","volume":"8","author":"Relan","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"3","key":"10.1016\/j.jiph.2026.103150_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac037","article-title":"The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta","volume":"29","author":"Liu","year":"2022","journal-title":"J Travel Med"},{"issue":"4","key":"10.1016\/j.jiph.2026.103150_bib28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajpath.2022.01.007","article-title":"Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with coronavirus disease 2019 caused by the omicron variant of severe acute respiratory syndrome coronavirus 2 in Houston, Texas","volume":"192","author":"Christensen","year":"2022","journal-title":"Am J Pathol"},{"issue":"10328","key":"10.1016\/j.jiph.2026.103150_bib29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jiph.2026.103150_bib30","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","article-title":"Monoclonal antibody therapies against SARS-CoV-2","volume":"22","author":"Focosi","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"10.1016\/j.jiph.2026.103150_bib31","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa2109682","article-title":"Subcutaneous REGEN-COV antibody combination to prevent Covid-19","volume":"385","author":"O'Brien","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:20:45Z","timestamp":1782199245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1876034126000225"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103150","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-exposure prophylaxis with favipiravir among household close contacts to confirmed COVID-19 cases: A cluster-randomized trial (PEPfavi)","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103150"}}